This inventor holds 2 USPTO granted patents. Top assignee: Tularik Limited. Active years: 1997-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-1998
Title: The Innovative Contributions of Jin-long Chen
Introduction
Jin-long Chen is a notable inventor based in Millbrae, CA, who has made significant contributions to the field of pharmacology. With a focus on obesity and diabetes research, he has developed innovative methods for screening pharmacological agents that regulate gene expression related to these conditions. His work has the potential to impact the treatment of obesity and type II diabetes mellitus.
Latest Patents
Jin-long Chen holds 2 patents that showcase his innovative approaches. His latest patents include:
1. **Drug screens for regulators of the expression of the obese gene** - This invention provides methods and compositions for screening pharmacological agents that regulate satiety, fat metabolism, and the expression of the ob gene in mammals. The assay involves contacting a mammalian adipocyte with a candidate agent and measuring the expression of a reporter to determine the agent's effect on ob gene expression.
2. **Transcriptional promoter of the murine obesity gene** - This invention relates to the Ob gene transcriptional promoter, which includes a C/EBP binding site and a novel untranslated Ob gene exon. These promoters are utilized in diagnosis and pharmaceutical development, particularly in high-throughput pharmaceutical screens using transfected adipocytes.
Career Highlights
Jin-long Chen has made significant strides in his career, particularly through his work at Tularik Limited. His research has focused on understanding the mechanisms of obesity and diabetes, leading to the development of innovative screening methods that could revolutionize treatment options.
Collaborations
Jin-long Chen collaborates with Fabienne Charles De La Brousse, contributing to the advancement of research in pharmacology and obesity-related studies.
Conclusion
Jin-long Chen's innovative work in the field of pharmacology, particularly regarding obesity and diabetes, highlights his contributions as an inventor. His patents reflect a commitment to advancing medical research and improving treatment options for these prevalent health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile